Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapa-Hospital: Dapagliflozin in Hospitalized T2D Patients
NCT05457933Phase 4Completed
- Sponsor
- Medanta
- Start
- Jul 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Medanta. Started Jul 2022; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05457933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05457933.